atai Life Sciences Announces Initiation of Phase 1 Trial for its...

PT359 – Sawyer Hurwitz – Art, Philosophy, Sexuality, and “Psychedelics Tonight”

Psilocybin in the Treatment of Alcohol Use Disorder

Clearmind Announces Notice of Proposed Stock Consolidation

MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT AND WELCOMES...

Clearmind Applies for Patent to Treat Obesity and Metabolic Syndrome

PT358 – Dr. Rick Barnett, Psy.D – Contexts of Use: Exploring...

Delix Therapeutics Expands World-Class Team with First Head of R&D

Numinus Expands Ketamine Therapy for Mental Health in Montreal and announces...

Psyence Group Completes Export of Psilocybin Mushrooms to Canada

Load more